The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?

References

• Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users: epidemiology, causes and intervention. Cambridge University Press, Cambridge, 2007
   Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study. Addict Behav 2002; 27: 155–166
   PubMed Web of Science ®Google Scholar
• Hubbard R L, Craddock S G, Flynn P M, Anderson J, Etheridge R M. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psych Addict Behav 1997; 11: 261–278
   Web of Science ®Google Scholar
• Ross J, Teesson M, Darke S. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005; 24: 411–418
   PubMed Web of Science ®Google Scholar
• Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005; 78: 309–315
   PubMed Web of Science ®Google Scholar
• Mills K, Teesson M, Lynskey M, Ross J, Darke S. Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2004; 27: 67–73
   PubMed Web of Science ®Google Scholar
• Grant B F, Dawson D A. Age of onset and its association with DSM-IV drug abuse and dependence: results form the National Longitudinal Alcohol Epidemiological Survey. J Substance Abuse 1998; 10: 163–173
   PubMedGoogle Scholar
• Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004; 23: 177–183
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M. Twelve month outcomes for heroin dependence treatments: does route of administration matter?. Drug Alcohol Rev 2005; 24: 165–171
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, Teesson M. Residential rehabilitation for the treatment of heroin dependence: sustained heroin abstinence and drug-related problems two years after treatment entrance. Addict Disorders Treat 2006; 5: 9–18
   Google Scholar
• Ross J, Teesson M, Darke S. Short-term outcomes for the treatment of heroin dependence: findings from Australian Treatment Outcome Study (ATOS). Addict Disorders Treat 2006; 5: 133–144
   Google Scholar
• Teesson M, Havard A, Ross J, Darke S. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006; 25: 241–247
   PubMed Web of Science ®Google Scholar
• Teesson M, Ross J, Darke S. The Australian Treatment Outcome Study (ATOS): 1 year follow-up results. Drug Alcohol Depend 2006; 83: 174–180
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2005; 28: 255–263
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, Teesson M. Heroin overdose, treatment exposure and client characteristics: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005; 24: 425–432
   PubMed Web of Science ®Google Scholar
• Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction 2001; 96: 1113–1125
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, Teesson M. Reductions in heroin use are not associated with increases in other drug use: two year findings from the Australian Treatment Outcome Study. Drug Alcohol Depend 2006; 84: 201–205
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M, Lynskey M. Health service utilisation and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003; 98: 1129–1135
   PubMed Web of Science ®Google Scholar
• Darke S, Havard A, Ross J, Mills K, Teesson M. Changes in the use of medical services and prescription drugs amongst heroin users over two years. Drug Alcohol Rev, in press
   Google Scholar
• Williamson A, Darke S, Ross J, Teesson M. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006; 25: 139–146
   Google Scholar
• Williamson A, Darke S, Ross J, Teesson M. The effects of persistence of cocaine use on 12 month outcomes for the treatment of heroin dependence. Drug Alcohol Depend 2006; 81: 293–300
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M, Lynskey M. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Drug Alcohol Depend 2004; 73: 1–10
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, Teesson M. Attempted suicide among heroin users: 12 month outcomes form the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2005; 78: 177–186
   PubMed Web of Science ®Google Scholar
• Havard A, Teesson M, Darke S, Ross J. Depression among heroin users: 12 month outcomes from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2006; 30: 355–362
   PubMed Web of Science ®Google Scholar
• Mills K L, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug Alcohol Depend 2005; 77: 243–249
   PubMed Web of Science ®Google Scholar
• Mills K L, Teesson M, Ross J, Darke S, Shanahan M A. The costs and outcomes of treatment for opioid dependence associated with Posttraumatic Stress Disorder. Psych Services 2005; 56: 940–945
   Google Scholar
• Najavits L M. Seeking safety: a treatment manual for PTSD and substance abuse. Guilford Press, New York 2002
   Google Scholar
• Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004; 74: 77–83
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Williamson A, Teesson M. The impact of Borderline Personality Disorder on 12 month outcomes for the treatment of heroin dependence. Addiction 2005; 100: 1121–1130
   PubMed Web of Science ®Google Scholar
• Strang J, McCambridge J, Best D. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003; 356: 959–960
   Google Scholar
• Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering ‘route transition interventions’. Drug Alcohol Rev 1999; 18: 441–445
   Web of Science ®Google Scholar